COVID-19 treatment derived from cows blood to be tested on humans

By BBN Staff: CNN reports that SAB Biotherapeutics, a South-Dakota based company is set to begin human trials next month on a COVID-19 treatment derived from the blood of cows.

An article published this week explains that the cows were genetically modified to have immune systems that are “part human” and that the treatment comes from harnessing the antibodies deriving from their modified immune systems.

Speaking to CNN, the CEO of SAB Biotherapeutics, Eddie Sullivan, said that the antibodies derived from the genetically tampered cows effectively killed the virus in laboratory conditions.

“We are eager to advance to the clinic as we move forward in the regulatory process with the hopes of bringing this potential COVID-19 therapeutic to patients in need of a solution,” Sullivan said.

The company noted that cows naturally have a more robust immune system than humans and that the antibodies derived from the cow plasma were found to be four times more potent than any antibody that came from a human source.

Similarly, another company Regeneron Pharmaceuticals, announced last week that it is set to begin human trials on a treatment derived from mice.

The company’s trials are said to determine whether or not their invention will be used as a treatment or a preventative measure.

Advertise with the mоѕt vіѕіtеd nеwѕ ѕіtе іn Belize ~ We offer fully customizable and flexible digital marketing packages. Your content is delivered instantly to thousands of users in Belize and abroad! Contact us at mаrkеtіng@brеаkіngbеlіzеnеwѕ.соm or call us at 501-612-0315.

© 2020, BreakingBelizeNews.com. Content is copyrighted and requires written permission for reprinting in online or print media. Theft of content without permission/payment is punishable by law.